Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of Nalbuphine After Intravenous and Intranasal Administration in Infants: A Single Center, Open-label, Prospective Study

NCT03059511 is registered in ClinicalTrials.gov with University Children's Hospital, Zurich as lead sponsor.

NCT NCT03059511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03059511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of Nalbuphine After Intravenous and Intranasal Administration in Infants: A Single Center, Open-label, Prospective Study
Lead sponsor
University Children's Hospital, Zurich
Phase
Phase 1
Overall status
Terminated
Start date
March 3, 2017
Completion date
January 10, 2018
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacokinetic